Kathy L. Hibbs
CIK: 0001267487
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Sep 8, 2026SOPH
SOPHiA GENETICS SA
Sale(S)Direct6.3K shares at avg. $8.13$51K - Aug 25, 2026SOPH
SOPHiA GENETICS SA
Sale(S)Direct6.3K shares at avg. $8.68$54K - Jun 18, 2026LAB
STANDARD BIOTOOLS INC.
Award(A)Direct99.1K shares- - Jun 18, 2026SOPH
SOPHiA GENETICS SA
Award(A)Direct19.7K shares at avg. $5.46$108K - May 12, 2026SOPH
SOPHiA GENETICS SA
Sale(S)Direct7.5K shares at avg. $4.67$35K - Jun 20, 2025LAB
STANDARD BIOTOOLS INC.
Award(A)Direct94.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 8, 2026 |  SOPH SOPHiA GENETICS SA | Sale(S) | 6,250 | $8.13 | $50,818 | Direct |
| Aug 25, 2026 | SOPH SOPHiA GENETICS SA | Sale(S) | 6,250 | $8.68 | $54,233 | Direct |
| Jun 18, 2026 |  LAB STANDARD BIOTOOLS INC. | Award(A) | 99,116 | - | $0 | Direct |
| Jun 18, 2026 | SOPH SOPHiA GENETICS SA | Award(A) | 19,724 | $5.46 | $107,693 | Direct |
| May 12, 2026 | SOPH SOPHiA GENETICS SA | Sale(S) | 7,508 | $4.67 | $35,037 | Direct |
| Jun 20, 2025 | LAB STANDARD BIOTOOLS INC. | Award(A) | 94,592 | - | - | Direct |
1-6 of 6 transactions
About HIBBS KATHY L
HIBBS KATHY L (SEC CIK 0001267487) files insider reports with the SEC as Director of SOPHiA GENETICS SA (SOPH) and Director of STANDARD BIOTOOLS INC. (LAB).
Signal8 holds 7 ownership filings by HIBBS KATHY L (1 Form 3, 6 Form 4), filed between Jun 24, 2025 and Sep 10, 2026. Those filings report 6 transactions, from Jun 20, 2025 to Sep 8, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on HIBBS KATHY L's filings is in BOSTON, MA.
Recent filings by HIBBS KATHY L
- Sep 8, 2026: Open-market sale of SOPH shares (Form 4, code S).
- Aug 25, 2026: Open-market sale of SOPH shares (Form 4, code S).
- Jun 18, 2026: Grant or award of LAB shares (Form 4, code A).
- Jun 18, 2026: Grant or award of SOPH shares (Form 4, code A).
- May 12, 2026: Open-market sale of SOPH shares (Form 4, code S).
Other insiders filing for SOPHiA GENETICS SA (SOPH)
- Menu Philippe, Chief Medical Officer
- Xu Zhenyu, Chief Scientific Officer
- Camblong Jurgi, Executive Chairman
- Van Well Daan, Chief Legal Officer
- Valente Manuela, Chief People Officer
- Verma Abhimanyu, Chief Technology Officer